Daniel T.  Scavilla net worth and biography

Daniel Scavilla Biography and Net Worth

Dan Scavilla has served as Globus Medical’s President and Chief Executive Officer since April 2022. He is also on our Board of Directors and is a member of our Nominating and Corporate Governance Committee. Mr. Scavilla began his career at Globus Medical as the Chief Financial Officer in May 2015. He then served as the Executive Vice President, Chief Commercial Officer and the President of Trauma. Prior to joining Globus, Mr. Scavilla spent 28 years in various positions within Johnson & Johnson, including serving as Chief Financial Officer, Global Vice President Finance & Business Operations of Johnson & Johnson Vision Care from February 2012 to December 2015, and as Chief Financial Officer, Worldwide Vice President Finance of Advanced Sterilization Products, the infection prevention branch of Johnson & Johnson Medical Devices from October 2007 to January 2012. Other prior roles at Johnson & Johnson include financial management positions at McNeil Consumer Healthcare, Centocor Biologics, and Cilag Schaffhausen Operations in Switzerland. Mr. Scavilla serves on the board of directors of Impulse Dynamics, a privately held company specializing in technology for treating heart conditions.

Mr. Scavilla received a B.S. in Finance and Organizational Behavior from LaSalle University, and holds an MBA in International Management from Temple University.

What is Daniel T. Scavilla's net worth?

The estimated net worth of Daniel T. Scavilla is at least $1.52 million as of April 10th, 2018. Mr. Scavilla owns 18,210 shares of Globus Medical stock worth more than $1,521,992 as of November 20th. This net worth evaluation does not reflect any other assets that Mr. Scavilla may own. Additionally, Mr. Scavilla receives an annual salary of $1,670,000.00 as EVP at Globus Medical. Learn More about Daniel T. Scavilla's net worth.

How old is Daniel T. Scavilla?

Mr. Scavilla is currently 59 years old. There are 4 older executives and no younger executives at Globus Medical. Learn More on Daniel T. Scavilla's age.

What is Daniel T. Scavilla's salary?

As the EVP of Globus Medical, Inc., Mr. Scavilla earns $1,670,000.00 per year. Learn More on Daniel T. Scavilla's salary.

How do I contact Daniel T. Scavilla?

The corporate mailing address for Mr. Scavilla and other Globus Medical executives is 2560 GENERAL ARMISTEAD AVENUE, AUDUBON PA, 19403. Globus Medical can also be reached via phone at (610) 930-1800 and via email at [email protected]. Learn More on Daniel T. Scavilla's contact information.

Has Daniel T. Scavilla been buying or selling shares of Globus Medical?

Daniel T. Scavilla has not been actively trading shares of Globus Medical during the last ninety days. Learn More on Daniel T. Scavilla's trading history.

Who are Globus Medical's active insiders?

Globus Medical's insider roster includes David Davidar (Director), David Demski (CEO), Robert Douglas (Director), Kelly Huller (SVP), Dan Lemaitre (Director), Leslie Norwalk (Director), Keith Pfeil (CFO), Ann Rhoads (Director), Daniel Scavilla (EVP), and James Tobin (Director). Learn More on Globus Medical's active insiders.

Are insiders buying or selling shares of Globus Medical?

During the last year, insiders at the medical device company sold shares 8 times. They sold a total of 204,890 shares worth more than $14,523,237.10. The most recent insider tranaction occured on November, 6th when CEO Daniel T. Scavilla sold 60,000 shares worth more than $4,801,200.00. Insiders at Globus Medical own 18.5% of the company. Learn More about insider trades at Globus Medical.

Information on this page was last updated on 11/6/2024.

Daniel T. Scavilla Insider Trading History at Globus Medical

See Full Table

Daniel T. Scavilla Buying and Selling Activity at Globus Medical

This chart shows Daniel T. Scavilla's buying and selling at Globus Medical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Globus Medical Company Overview

Globus Medical logo
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
Read More

Today's Range

Now: $83.58
Low: $82.35
High: $83.91

50 Day Range

MA: $74.16
Low: $69.33
High: $83.58

2 Week Range

Now: $83.58
Low: $44.02
High: $84.87

Volume

1,038,264 shs

Average Volume

1,056,515 shs

Market Capitalization

$11.38 billion

P/E Ratio

124.75

Dividend Yield

N/A

Beta

1.17